𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Decreasing serum alpha-fetoprotein levels in predicting poor prognosis of acute hepatic failure in patients with chronic hepatitis B

✍ Scribed by Sien-Sing Yang; Ken-Sheng Cheng; Yung-Chih Lai; Chi-Hwa Wu; Tzen-Kwan Chen; Chia-Long Lee; Ding-Shinn Chen

Publisher
Springer Japan
Year
2002
Tongue
English
Weight
68 KB
Volume
37
Category
Article
ISSN
0944-1174

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Hepatitis B virus-DNA in the serum of pa
Hepatitis B virus-DNA in the serum of patients followed-up longitudinally with acute and chronic hepatitis B
✍ Dr. T. Moestrup; B. G. Hansson; A. Widell; J. Blomberg; E. Nordenfelt πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 483 KB πŸ‘ 2 views

Sera from 79 patients with acute self-limiting hepatitis, 17 patients with acute hepatitis B evolving into chronic HBsAg carriership, and 43 chronic HBsAg carriers without a history of acute hepatitis were analyzed for presence of hepatitis B virus (HBV)-DNA by a molecular hybridization technique. I

High serum interleukin-6 level predicts
High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B
✍ Vincent Wai-Sun Wong; Jun Yu; Alfred Sze-Lok Cheng; Grace Lai-Hung Wong; Hoi-Yun πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 102 KB

## Abstract Increased interleukin‐6 (IL‐6) production is implicated in the pathogenesis of hepatocellular carcinoma (HCC) in animal models. Although previous studies showed that HCC patients had higher serum IL‐6 level at the time of diagnosis, it is unclear if the cytokine contributes to the devel

Correlation of serum hepatitis B surface
Correlation of serum hepatitis B surface antigen level with response to entecavir in naΓ―ve patients with chronic hepatitis B
✍ Myoung Hee Lee; Da Mi Lee; Soon Sun Kim; Jae Youn Cheong; Sung Won Cho πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 117 KB πŸ‘ 2 views

## Abstract Recent studies have suggested that quantifying the serum HBsAg levels can predict the response to pegylated interferon. We aimed to determine the change in serum HBsAg levels during entecavir (ETV) treatment and the correlation with treatment response in chronic HBeAg‐positive and HBeAg

Serum titers of pre-S(2) antigen in pati
Serum titers of pre-S(2) antigen in patients with acute and chronic type B hepatitis: Relation to serum aminotransferase activity and other hepatitis b virus markers
✍ Kiyohiko Kurai; Shiro Iino; Kazuhiko Koike; Keiji Mitamura; Yasuo Endo; Hiroshi πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 503 KB

The peptide which is encoded by the pre-S(2) region of hepatitis B virus DNA, the pre-S(2) antigen, was determined quantitatively by an enzyme immunoassay system employing monoclonal antibodies. The prevalence and titer of pre-S(2)Ag were 91.9% (91/99) and 10,356 2 19,053 units (mean f S.D., arbitra